NCT03096379

Brief Summary

It is clinically challenging to differentiate Crohn's disease from gut tuberculosis especially in regions endemic of tuberculosis infection. The investigators plan to perform magnetic resonance enterography (MRE) who presented to our hospital in Shenzhen, China for new onset of lower gastrointestinal symptoms and ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy. MRE findings will be independently interpreted by two radiologistsThe role of MRE in distinguishing gut tuberculosis from Crohn's disease will be determined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 30, 2014

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 15, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 30, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2019

Completed
Last Updated

April 17, 2019

Status Verified

April 1, 2019

Enrollment Period

4 years

First QC Date

March 15, 2017

Last Update Submit

April 15, 2019

Conditions

Keywords

TBCDMREileocecal

Outcome Measures

Primary Outcomes (1)

  • Small / large bowel transmural enhancement

    Via magnetic resonance enterography independently interpreted by two radiologist with expertise

    During procedure

Secondary Outcomes (3)

  • Skip lesions in small / large bowel

    During procedure

  • Vascular engorgement

    During procedure

  • Mesenteric combing

    During procedure

Study Arms (1)

Magnetic resonance imaging

Patients with new-onset of lower gastrointestinal symptoms and ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy.

Diagnostic Test: Magnetic resonance imaging

Interventions

Enterography performed via magnetic resonance imaging

Magnetic resonance imaging

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive patients with new-onset of lower gastrointestinal symptoms and ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy.

You may qualify if:

  • New-onset lower gastrointestinal symptoms of less than 3 months
  • Ileocecal mucosal lesions of uncertain diagnosis as evidenced by the presence of inflammation, ulceration, strictures or nodules on colonoscopy.
  • No prior tuberculosis treatment
  • No prior immunomodulatory or anti-tumor necrosis factor treatment

You may not qualify if:

  • Stage 4 or 5 chronic kidney disease, i.e. a glomerular filtration rate of \<=30 ml/min.
  • Contraindications to magnetic resonance imaging, including the installation of metallic devices or implants in-situ (e.g. pacemakers)
  • Prior intestinal resection
  • Known concomitant chronic small / large bowel disease, including ulcerative colitis, eosinophilic gastroenteritis, NSAID-related enterography etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Hong Kong-Shenzhen Hospital

Shenzhen, Guangdong, China

Location

MeSH Terms

Conditions

Crohn Disease

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Wai-Kay Seto, MD

    The University of Hong Kong-Shenzhen Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

March 15, 2017

First Posted

March 30, 2017

Study Start

December 30, 2014

Primary Completion

December 30, 2018

Study Completion

March 30, 2019

Last Updated

April 17, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations